Treatment of cryptosporidiosis with paromomycin

A report of five cases

Keith Armitage, Timothy Flanigan, John Carey, Ian Frank, Rob Roy MacGregor, Paul Ross, Richard Goodgame, John Turner

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Cryptosporidiosis continues to be one of the most devastating complications of the acquired immunodeficiency syndrome, causing severe, chronic diarrhea that is largely refractory to treatment. More than 60 drugs have been tried in the treatment of Cryptosporidiosis, none of which have been consistently successful. We describe the successful treatment of Cryptosporidiosis in five patients with acquired immunodeficiency syndrome with oral paromomycin at a dose of 1500 to 2000 mg/d. All five patients had resolution of symptoms and normalization of bowel movements, although one patient later relapsed while receiving paromomycin. Three of five patients cleared Cryptosporidium from the stool. Paromomycin is a promising therapy for Cryptosporidiosis in acquired immunodeficiency syndrome and further prospective clinical trials are warranted.

Original languageEnglish (US)
Pages (from-to)2497-2499
Number of pages3
JournalArchives of Internal Medicine
Volume152
Issue number12
StatePublished - 1992
Externally publishedYes

Fingerprint

Paromomycin
Cryptosporidiosis
Acquired Immunodeficiency Syndrome
Cryptosporidium
Therapeutics
Diarrhea
Clinical Trials
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Armitage, K., Flanigan, T., Carey, J., Frank, I., MacGregor, R. R., Ross, P., ... Turner, J. (1992). Treatment of cryptosporidiosis with paromomycin: A report of five cases. Archives of Internal Medicine, 152(12), 2497-2499.

Treatment of cryptosporidiosis with paromomycin : A report of five cases. / Armitage, Keith; Flanigan, Timothy; Carey, John; Frank, Ian; MacGregor, Rob Roy; Ross, Paul; Goodgame, Richard; Turner, John.

In: Archives of Internal Medicine, Vol. 152, No. 12, 1992, p. 2497-2499.

Research output: Contribution to journalArticle

Armitage, K, Flanigan, T, Carey, J, Frank, I, MacGregor, RR, Ross, P, Goodgame, R & Turner, J 1992, 'Treatment of cryptosporidiosis with paromomycin: A report of five cases', Archives of Internal Medicine, vol. 152, no. 12, pp. 2497-2499.
Armitage K, Flanigan T, Carey J, Frank I, MacGregor RR, Ross P et al. Treatment of cryptosporidiosis with paromomycin: A report of five cases. Archives of Internal Medicine. 1992;152(12):2497-2499.
Armitage, Keith ; Flanigan, Timothy ; Carey, John ; Frank, Ian ; MacGregor, Rob Roy ; Ross, Paul ; Goodgame, Richard ; Turner, John. / Treatment of cryptosporidiosis with paromomycin : A report of five cases. In: Archives of Internal Medicine. 1992 ; Vol. 152, No. 12. pp. 2497-2499.
@article{3a98ea0113974a1590453e606756b605,
title = "Treatment of cryptosporidiosis with paromomycin: A report of five cases",
abstract = "Cryptosporidiosis continues to be one of the most devastating complications of the acquired immunodeficiency syndrome, causing severe, chronic diarrhea that is largely refractory to treatment. More than 60 drugs have been tried in the treatment of Cryptosporidiosis, none of which have been consistently successful. We describe the successful treatment of Cryptosporidiosis in five patients with acquired immunodeficiency syndrome with oral paromomycin at a dose of 1500 to 2000 mg/d. All five patients had resolution of symptoms and normalization of bowel movements, although one patient later relapsed while receiving paromomycin. Three of five patients cleared Cryptosporidium from the stool. Paromomycin is a promising therapy for Cryptosporidiosis in acquired immunodeficiency syndrome and further prospective clinical trials are warranted.",
author = "Keith Armitage and Timothy Flanigan and John Carey and Ian Frank and MacGregor, {Rob Roy} and Paul Ross and Richard Goodgame and John Turner",
year = "1992",
language = "English (US)",
volume = "152",
pages = "2497--2499",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Treatment of cryptosporidiosis with paromomycin

T2 - A report of five cases

AU - Armitage, Keith

AU - Flanigan, Timothy

AU - Carey, John

AU - Frank, Ian

AU - MacGregor, Rob Roy

AU - Ross, Paul

AU - Goodgame, Richard

AU - Turner, John

PY - 1992

Y1 - 1992

N2 - Cryptosporidiosis continues to be one of the most devastating complications of the acquired immunodeficiency syndrome, causing severe, chronic diarrhea that is largely refractory to treatment. More than 60 drugs have been tried in the treatment of Cryptosporidiosis, none of which have been consistently successful. We describe the successful treatment of Cryptosporidiosis in five patients with acquired immunodeficiency syndrome with oral paromomycin at a dose of 1500 to 2000 mg/d. All five patients had resolution of symptoms and normalization of bowel movements, although one patient later relapsed while receiving paromomycin. Three of five patients cleared Cryptosporidium from the stool. Paromomycin is a promising therapy for Cryptosporidiosis in acquired immunodeficiency syndrome and further prospective clinical trials are warranted.

AB - Cryptosporidiosis continues to be one of the most devastating complications of the acquired immunodeficiency syndrome, causing severe, chronic diarrhea that is largely refractory to treatment. More than 60 drugs have been tried in the treatment of Cryptosporidiosis, none of which have been consistently successful. We describe the successful treatment of Cryptosporidiosis in five patients with acquired immunodeficiency syndrome with oral paromomycin at a dose of 1500 to 2000 mg/d. All five patients had resolution of symptoms and normalization of bowel movements, although one patient later relapsed while receiving paromomycin. Three of five patients cleared Cryptosporidium from the stool. Paromomycin is a promising therapy for Cryptosporidiosis in acquired immunodeficiency syndrome and further prospective clinical trials are warranted.

UR - http://www.scopus.com/inward/record.url?scp=0026615148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026615148&partnerID=8YFLogxK

M3 - Article

VL - 152

SP - 2497

EP - 2499

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 12

ER -